77 related articles for article (PubMed ID: 12963987)
21. Suppression of IkappaBalpha expression is necessary for c-Jun N-terminal kinase-mediated enhancement of Fas cytotoxicity.
Chang NS; Schultz L; Heath J
Biochem Biophys Res Commun; 2000 Jul; 274(1):4-10. PubMed ID: 10903887
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of IkappaBalpha nuclear export as an approach to abrogate nuclear factor-kappaB-dependent cancer cell survival.
O'Connor S; Shumway S; Miyamoto S
Mol Cancer Res; 2005 Jan; 3(1):42-9. PubMed ID: 15671248
[TBL] [Abstract][Full Text] [Related]
23. Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer.
Liptay S; Weber CK; Ludwig L; Wagner M; Adler G; Schmid RM
Int J Cancer; 2003 Jul; 105(6):735-46. PubMed ID: 12767057
[TBL] [Abstract][Full Text] [Related]
24. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
25. Curcumin suppresses growth of head and neck squamous cell carcinoma.
LoTempio MM; Veena MS; Steele HL; Ramamurthy B; Ramalingam TS; Cohen AN; Chakrabarti R; Srivatsan ES; Wang MB
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6994-7002. PubMed ID: 16203793
[TBL] [Abstract][Full Text] [Related]
26. HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin.
Chen SZ; Jiang M; Zhen YS
Cancer Chemother Pharmacol; 2005 Aug; 56(2):212-20. PubMed ID: 15812674
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of chemosensitivity toward peplomycin by calpastatin-stabilized NF-kappaB p65 in esophageal carcinoma cells: possible involvement of Fas/Fas-L synergism.
Liu TL; Shimada H; Ochiai T; Shiratori T; Lin SE; Kitagawa M; Harigaya K; Maki M; Oka M; Abe T; Takiguchi M; Hiwasa T
Apoptosis; 2006 Jun; 11(6):1025-37. PubMed ID: 16547594
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
29. Enhanced radiosensitization and chemosensitization in NF-kappaB-suppressed human oral cancer cells via the inhibition of gamma-irradiation- and 5-FU-induced production of IL-6 and IL-8.
Tamatani T; Azuma M; Ashida Y; Motegi K; Takashima R; Harada K; Kawaguchi S; Sato M
Int J Cancer; 2004 Mar; 108(6):912-21. PubMed ID: 14712497
[TBL] [Abstract][Full Text] [Related]
30. Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Jin F; Liu X; Zhou Z; Yue P; Lotan R; Khuri FR; Chung LW; Sun SY
Cancer Res; 2005 Jul; 65(14):6354-63. PubMed ID: 16024638
[TBL] [Abstract][Full Text] [Related]
31. cIAP-2 protects cardiac fibroblasts from oxidative damage: an obligate regulatory role for ERK1/2 MAPK and NF-κB.
Philip L; Shivakumar K
J Mol Cell Cardiol; 2013 Sep; 62():217-26. PubMed ID: 23837962
[TBL] [Abstract][Full Text] [Related]
32. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor (EGF) activates nuclear factor-kappaB through IkappaBalpha kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IkappaBalpha.
Sethi G; Ahn KS; Chaturvedi MM; Aggarwal BB
Oncogene; 2007 Nov; 26(52):7324-32. PubMed ID: 17533369
[TBL] [Abstract][Full Text] [Related]
34. Activation of NF-kappaB is required for PDGF-B chain to transform NIH3T3 cells.
Shimamura T; Hsu TC; Colburn NH; Bejcek BE
Exp Cell Res; 2002 Mar; 274(1):157-67. PubMed ID: 11855867
[TBL] [Abstract][Full Text] [Related]
35. Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.
Cilloni D; Messa F; Rosso V; Arruga F; Defilippi I; Carturan S; Catalano R; Pautasso M; Panuzzo C; Nicoli P; Messa E; Morotti A; Iacobucci I; Martinelli G; Bracco E; Saglio G
Leukemia; 2008 Jun; 22(6):1234-40. PubMed ID: 18401421
[TBL] [Abstract][Full Text] [Related]
36. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
[TBL] [Abstract][Full Text] [Related]
37. Adenovirus-mediated inhibition of NF-kappaB confers chemo-sensitization and apoptosis in prostate cancer cells.
Flynn V; Ramanitharan A; Moparty K; Davis R; Sikka S; Agrawal KC; Abdel-Mageed AB
Int J Oncol; 2003 Aug; 23(2):317-23. PubMed ID: 12851680
[TBL] [Abstract][Full Text] [Related]
38. Metallothionein mediates the level and activity of nuclear factor kappa B in murine fibroblasts.
Butcher HL; Kennette WA; Collins O; Zalups RK; Koropatnick J
J Pharmacol Exp Ther; 2004 Aug; 310(2):589-98. PubMed ID: 15039454
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Jurkat acute T-lymphocytic leukemia cells by onconase (Ranpirnase) is accompanied by an altered nucleocytoplasmic distribution and reduced expression of transcription factor NF-kappaB.
Tsai SY; Ardelt B; Hsieh TC; Darzynkiewicz Z; Shogen K; Wu JM
Int J Oncol; 2004 Dec; 25(6):1745-52. PubMed ID: 15547713
[TBL] [Abstract][Full Text] [Related]
40. Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation.
Luan B; Zhang Z; Wu Y; Kang J; Pei G
EMBO J; 2005 Dec; 24(24):4237-46. PubMed ID: 16308565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]